[Sermion treatment of middle-aged and elderly patients with initial atherosclerotic encephalopathy].
The authors report results of a clinico-physiological study of the efficacy of a vasoactive agent sermion in patients with initial atherosclerotic encephalopathy indicating a positive effect of course treatment with this agent on the main clinical manifestations of the disease, pulse blood filling, bioelectric activity of the brain, psychomotor rate, mental working capacity, mnemonic function. Considering the established age-related differences in the efficacy of the agent, it is expedient to recommend sermion for long-term employment in the elderly. One should be cautious in instituting the drug in persons suffering of raised intraocular pressure.
Man'kovskiĭ
N B
NB
Mints
A Ia
AIa
Bachinskaia
N Iu
NIu
Kochubeĭ
N V
NV
D000368:Aged; D004341:Drug Evaluation; D004569:Electroencephalography; D004873:Ergolines / Q000627:therapeutic use*; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D008297:Male; D008875:Middle Aged; D009530:Nicergoline / Q000627:therapeutic use*; D011581:Psychological Tests; D013607:Tablets; D013997:Time Factors
D004873:Ergolines; D013607:Tablets; D009530:Nicergoline
Lechenie sermionom bol'nykh nachal'noĭ ateroskleroticheskoĭ éntsefalopatieĭ srednego i pozhilogo vozrasta.